摘要
为研究红细胞不规则抗体与无效输注的关系,通过对我院2017年6月—2018年6月的1 837名患者输血后效果评价,对158名发生无效输注的患者应用增强检测方法进行红细胞不规则抗体检测及鉴定。在发生无效输注的158名患者中,有19名检测出不规则抗体。说明红细胞不规则抗体可引起无效输注,在今后的工作中应尽量做到同型输注,减少不规则抗体的产生,降低红细胞无效输注的发生。
To study the relationship between irregular erythrocyte antibody and invalid transfusion. After blood transfusion,1837 patients in our hospital from June 2017 to June 2018 were evaluated,and 158 patients with invalid infusion were tested and identified by enhanced antibody detection. Irregular antibodies were detected in 19 of the 158 patients who had an ineffective infusion. Irregular antibodies of erythrocytes can cause invalid transfusion. In the future work,we should try to achieve the same type of transfusion,so as to reduce the production of irregular antibodies and reduce the occurrence of invalid transfusion of erythrocytes.
引文
[1]吕运来,贠中桥,兰炯采,等.红细胞无效输注回顾性初探[J].中国输血杂志,2007,20(03)220-221.
[2]刘景汉,汪德清,兰炯采.临床输血学.北京:人民卫生出版社,2011:442-443.
[3]赵颖欣,王德辉,柴慧丽,等.血型不规则抗体筛查用于预防和降低临床无效输血的发生[J].中国输血杂志,2015,28(01):48-50.
[4]胡丽华.临床输血血检验技术[M].北京:人民卫生出版社,2015:30-32.
[5]刘达庄.免疫血液学[M].上海:上海科技出版社,2002:190-191.
[6]桂荣,张志昇,王勇军.输血相容性检测及疑难病例分析[M].北京:人民卫生出版社,2018:8-9.